Parsabiv 5 mg in 1 mL Injection
RxNorm 1876136
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1876136 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Parsabiv 5 mg in 1 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
1 mL etelcalcetide 5 mg/ML Injection [Parsabiv]
(Atom ID: 8741342)
PSNPrescribable
Prescribable Name (PSN):
Parsabiv 5 mg in 1 mL Injection
(Atom ID: 8741362)
SYPrescribable
Synonym (SY):
Parsabiv 5 mg per 1 mL Injection
(Atom ID: 8741364)
SYPrescribable
Synonym (SY):
Parsabiv 5 mg/ML per 1 mL Injection
(Atom ID: 8741363)
Patient Education
Etelcalcetide Injection
Etelcalcetide injection is used to treat secondary hyperparathyroidism (condition in which the body produces too much parathyroid hormone [PTH; natural substance needed to control the amount of calcium in the blood]) in adults with chronic kidney disease (condition in which the kidneys stop working slowly and gradually) who are being treated with dialysis (medical treatment to clean the blood when the kidneys are not working properly.) Etelcalcetide injection is in a class of medications called calcimimetics. It works by signaling the body to produce less parathyroid hormone in order to decrease the amount of calcium in the blood.
[Learn More]
* Please review the disclaimer below.